These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 14695323)

  • 21. Reduction of metastasis, cell invasion, and adhesion in mouse osteosarcoma by YM529/ONO-5920-induced blockade of the Ras/MEK/ERK and Ras/PI3K/Akt pathway.
    Tsubaki M; Satou T; Itoh T; Imano M; Ogaki M; Yanae M; Nishida S
    Toxicol Appl Pharmacol; 2012 Mar; 259(3):402-10. PubMed ID: 22326785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased K-ras protein and activity in mouse and human lung epithelial cells at confluence.
    Kammouni W; Ramakrishna G; Sithanandam G; Smith GT; Fornwald LW; Masuda A; Takahashi T; Anderson LM
    Cell Growth Differ; 2002 Sep; 13(9):441-8. PubMed ID: 12354753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular mechanisms of deguelin-induced apoptosis in transformed human bronchial epithelial cells.
    Lee HY
    Biochem Pharmacol; 2004 Sep; 68(6):1119-24. PubMed ID: 15313408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. K-ras mutation promotes ionizing radiation-induced invasion and migration of lung cancer in part via the Cathepsin L/CUX1 pathway.
    Wang L; Zhao Y; Xiong Y; Wang W; Fei Y; Tan C; Liang Z
    Exp Cell Res; 2018 Jan; 362(2):424-435. PubMed ID: 29246726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung.
    Rodenhuis S; Slebos RJ; Boot AJ; Evers SG; Mooi WJ; Wagenaar SS; van Bodegom PC; Bos JL
    Cancer Res; 1988 Oct; 48(20):5738-41. PubMed ID: 3048648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Codon 12 and codon 13 mutations at the K-ras gene induce different soft tissue sarcoma types in nude mice.
    Guerrero S; Figueras A; Casanova I; Farré L; Lloveras B; Capellà G; Trias M; Mangues R
    FASEB J; 2002 Oct; 16(12):1642-4. PubMed ID: 12207005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutations in FGFR3 and PIK3CA, singly or combined with RAS and AKT1, are associated with AKT but not with MAPK pathway activation in urothelial bladder cancer.
    Juanpere N; Agell L; Lorenzo M; de Muga S; López-Vilaró L; Murillo R; Mojal S; Serrano S; Lorente JA; Lloreta J; Hernández S
    Hum Pathol; 2012 Oct; 43(10):1573-82. PubMed ID: 22417847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis].
    Irie K; Ishida H; Furukawa T; Koyanagi K; Miyamoto Y
    Rinsho Byori; 1996 Jan; 44(1):32-41. PubMed ID: 8691638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oncogenic Ras, but not (V600E)B-RAF, protects from cholesterol depletion-induced apoptosis through the PI3K/AKT pathway in colorectal cancer cells.
    Calleros L; Sánchez-Hernández I; Baquero P; Toro MJ; Chiloeches A
    Carcinogenesis; 2009 Oct; 30(10):1670-7. PubMed ID: 19700418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C-erbB-2 expression and codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas.
    Kern JA; Slebos RJ; Top B; Rodenhuis S; Lager D; Robinson RA; Weiner D; Schwartz DA
    J Clin Invest; 1994 Feb; 93(2):516-20. PubMed ID: 7906694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Claudin-18 inhibits cell proliferation and motility mediated by inhibition of phosphorylation of PDK1 and Akt in human lung adenocarcinoma A549 cells.
    Shimobaba S; Taga S; Akizuki R; Hichino A; Endo S; Matsunaga T; Watanabe R; Yamaguchi M; Yamazaki Y; Sugatani J; Ikari A
    Biochim Biophys Acta; 2016 Jun; 1863(6 Pt A):1170-8. PubMed ID: 26919807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Up-regulated caveolin-1 accentuates the metastasis capability of lung adenocarcinoma by inducing filopodia formation.
    Ho CC; Huang PH; Huang HY; Chen YH; Yang PC; Hsu SM
    Am J Pathol; 2002 Nov; 161(5):1647-56. PubMed ID: 12414512
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Lu XX; Cao LY; Chen X; Xiao J; Zou Y; Chen Q
    Biomed Res Int; 2016; 2016():2476842. PubMed ID: 27822469
    [No Abstract]   [Full Text] [Related]  

  • 34. K-ras p21 expression and activity in lung and lung tumors.
    Ramakrishna G; Sithanandam G; Cheng RY; Fornwald LW; Smith GT; Diwan BA; Anderson LM
    Exp Lung Res; 2000 Dec; 26(8):659-71. PubMed ID: 11195463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activated forms of H-RAS and K-RAS differentially regulate membrane association of PI3K, PDK-1, and AKT and the effect of therapeutic kinase inhibitors on cell survival.
    Carón RW; Yacoub A; Li M; Zhu X; Mitchell C; Hong Y; Hawkins W; Sasazuki T; Shirasawa S; Kozikowski AP; Dennis PA; Hagan MP; Grant S; Dent P
    Mol Cancer Ther; 2005 Feb; 4(2):257-70. PubMed ID: 15713897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-200 promotes lung cancer cell growth through FOG2-independent AKT activation.
    Guo L; Wang J; Yang P; Lu Q; Zhang T; Yang Y
    IUBMB Life; 2015 Sep; 67(9):720-5. PubMed ID: 26314828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ras inhibitors display an anti-metastatic effect by downregulation of lysyl oxidase through inhibition of the Ras-PI3K-Akt-HIF-1α pathway.
    Yoshikawa Y; Takano O; Kato I; Takahashi Y; Shima F; Kataoka T
    Cancer Lett; 2017 Dec; 410():82-91. PubMed ID: 28951129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significantly inhibitory effects of low molecular weight heparin (Fraxiparine) on the motility of lung cancer cells and its related mechanism.
    Zhong GX; Gong Y; Yu CJ; Wu SF; Ma QP; Wang Y; Ren J; Zhang XC; Yang WH; Zhu W
    Tumour Biol; 2015 Jun; 36(6):4689-97. PubMed ID: 25619477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of tumor induction and progression of oncogenic K-ras-positive tumors in the presence of TGF- b1 haploinsufficiency.
    Pandey J; Umphress SM; Kang Y; Angdisen J; Naumova A; Mercer KL; Jacks T; Jakowlew SB
    Carcinogenesis; 2007 Dec; 28(12):2589-96. PubMed ID: 17690114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Colorectal Carcinogenesis: Connecting K-RAS-Induced Transformation and CREB Activity In Vitro and In Vivo.
    Steven A; Heiduk M; Recktenwald CV; Hiebl B; Wickenhauser C; Massa C; Seliger B
    Mol Cancer Res; 2015 Aug; 13(8):1248-62. PubMed ID: 25934695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.